This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Saltevo, J. Articles by Laakso, M. Search for Related Content PubMed PubMed Citation Articles by Saltevo, J. Articles by Laakso, M. Social Bookmarking                         What's this?

Levels of adiponectin, C-reactive protein and interleukin-1 receptor antagonist are associated with the relative change in body mass index between childhood and adulthood

Department of Internal Medicine, Central Hospital of Middle Finland, 40620 Jyväskylä, Finland.

Mauno Vanhala

Laukaa Health Center, Laukaa, and Unit of General Practice, Central Hospital of Middle Finland, Jyväskylä and University of Kuopio, Finland.

Hannu Kautiainen

Rheumatism Foundation Hospital, Heinola, Finland

Markku Laakso

Department of Medicine, University of Kuopio and Kuopio University Hospital, Finland

Obesity has been related to subclinical inflammation and decreased levels of adiponectin. We examined the relationship between inflammatory markers and adiponectin and the change in body mass index (BMI) between childhood and adulthood. Our study included 368 subjects (176 men and 192 women) from a population-based cohort whose weight and height had been recorded at the age of seven years. They participated in this study as adults (with a mean age of 46 years); levels of adiponectin, interleukin-1 receptor antagonist (IL-1 Ra) and high-sensitivity C-reactive protein (hs-CRP) were measured. The relative change of BMI from childhood to adulthood was significantly associated with levels of IL-1 Ra (men: r=0.27 [95% CI: 0.12 to 0.40] and women: 0.64 [0.55 to 0.72]), hs-CRP (r=0.15 and 0.52, respectively) and adiponectin (r=–0.13 and –0.29, respectively) in both genders.

Decreased levels of adiponectin and elevated levels of IL-1 Ra and hs-CRP at adulthood appear to be related to the change in BMI between childhood and adulthood.

Key Words: adiponectin • C-reactive protein • interleukin 1 receptor antagonist • obesity • relative weight change.

References

• 1. Reaven GM. Banting Lecture 1988: role of insulin resistance in human diabetes. Diabetes 1988;37:1595–607.[Abstract]
• 2. Trayhurn P Beattie HJ. Physiological role of adipose tissue: white adipose tissue as endocrine and secretory organ. Proc Nutr Soc 2001;60:329–39.[Web of Science][Medline] [Order article via Infotrieve]
• 3. Weyer C Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930–5.[Abstract/Free Full Text]
• 4. Kumada M Kihara S, Sumitsuji S et al. for Osaka CAD Study Group. Coronary artery disease. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23(1):85–9.[Abstract/Free Full Text]
• 5. Bacha F Saad R, Gungor N, Arslanian AS. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 2004;27:547–52.[Abstract/Free Full Text]
• 6. Wang Y Lam KS, Xu JY et al. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 2005;280:18341–7.[Abstract/Free Full Text]
• 7. Yudkin JS Kumari M, Humpries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 1999;148:209–14.[Web of Science]
• 8. Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003;24:278–301.[Abstract/Free Full Text]
• 9. Pearson TA Mensah GA, Alexander RW et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499–511.[Free Full Text]
• 10. Verma S Yeh TE. C-reactive protein and atherothrombosis – beyond a biomarker: an actual partaker of lesion formation. Am J Physiol Regul Integr Comp Physiol 2003;285:R1253–R1256.[Free Full Text]
• 11. Laaksonen DE Niskanen L, Nyyssönen K et al. C-reactive protein and development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 2004;47:1403–10.[Web of Science][Medline] [Order article via Infotrieve]
• 12. Gabay C Kushner I Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448–54.[Free Full Text]
• 13. Salmenniemi U Ruotsalainen E, Pihlajamäki J et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 2004;110:3842–8.[Abstract/Free Full Text]
• 14. Patti G D'Ambrosio A, Dobrina A et al. Interleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery disease. J Thromb Thrombolysis 2002;14:139–43.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 15. Pietrobelli A Faith MS, Allison DB, Gallagher D, Chiumello G, Heymsfield BS. Body mass index as a measure of adiposity among children and adolescents: a validation study. J Pediatr 1998;132:204–10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 16. Bellizzi MC Dietz HW. Workshop on childhood obesity: summary of the discussion. Am J Clin Nutr 1999;70:173S–175S.[Web of Science][Medline] [Order article via Infotrieve]
• 17. Warren M Schreiner PJ, Terry GJ. The relation between visceral fat measurement and torso level – is one level better than another? The Atherosclerosis Risk in Communities Study, 1990-1992. Am J Epidemiol 2006;163:352–8.[Abstract/Free Full Text]
• 18. Westerbacka J Cornér A, Tiikkainen M et al. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 2004;47:1360–9.[Web of Science][Medline] [Order article via Infotrieve]
• 19. Thorand B Baumert J, Döring A et al. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 2006;184:216–24.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 20. Maedler K Sergeev P, Ris F et al. Glucose-induced beta-cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002;110:851–60.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 21. Meier CA Bobbioni E, Gabay C, Assimacopoulos-Jeannet F, Golay A, Dayer JM. IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? J Clin Endocrinol Metab 2002;87:1184–8.[Abstract/Free Full Text]
• 22. Juge-Aubry CE, Somm E, Giusti V et al. Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes 2003;52:1104–10.[Abstract/Free Full Text]
• 23. Ruotsalainen E Salmenniemi U, Vauhkonen I et al. Changes in inflammatory cytokines are related to impaired glucose tolerance in offspring of type 2 diabetic subjects. Diabetes Care 2006;29:2714–20.[Abstract/Free Full Text]
• 24. Arend WP Gabay C Physiologic role of interleukin-1 receptor antagonist. Arthritis Res 2000;2:245–8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 25. Larsen CM Faulenbach M, Vaag A et al. Interleukin-1 receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007;356:1517–26.[Abstract/Free Full Text]
• 26. Tilg H Moschen RA. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772–83.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 27. Weyer C Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930–5.[Abstract/Free Full Text]
• 28. Pischon T Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm BE. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004;291:1730–7.[Abstract/Free Full Text]
• 29. Narayan KMV Boyle J, Thompson TJ, Gregg EW, Williamson DF. Effect of BMI on lifetime risk for diabetes in the US. Diabetes Care 2007;30:1562–6.[Abstract/Free Full Text]
• 30. Matsubara M Namioka K, Katayose S. Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation. Eur J Endocrinol 2003;148:657–62.[Abstract]
• 31. Engström G, Hedblad B, Stavenow L, Lind P, Janzon L, Lindgärde F. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes 2003;52:2097–101.[Abstract/Free Full Text]
• 32. Vozarova B Stefan N, Lindsay RS et al. Low plasma adiponectin concentrations do not predict weight gain in humans. Diabetes 2002;51:2964–7.[Abstract/Free Full Text]

Diabetes and Vascular Disease Research, Vol. 4, No. 4, 328-331 (2007)
DOI: 10.3132/dvdr.2007.060


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. Stehno-Bittel Intricacies of Fat Physical Therapy, November 1, 2008; 88(11): 1265 - 1278. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Saltevo, J. Articles by Laakso, M. Search for Related Content PubMed PubMed Citation Articles by Saltevo, J. Articles by Laakso, M. Social Bookmarking                         What's this?